Topic:

Influenza

Latest Headlines

Latest Headlines

HHS awards flu antigen contract to CSL

CSL will manufacture and store antigens that can be used against influenza strains with pandemic potential.

Flu adjuvant adds promise to vaccine

Researchers at Oxford University discovered a compound that gives vaccines a little extra might in the fight against viruses such as the flu, HIV and herpes in mice.

Study: Flu vaccine safe for pregnant women

A new study further proves the flu vaccine is safe for pregnant women. The study of nearly 9,000 pregnant women who received the vaccine showed no significant increase in rates of major birth defects, Reuters reports.

FDA approves 6 flu vaccines

The FDA green lighted influenza vaccines from all 6 vaccine manufacturers licensed to produce and distribute in the U.S., making way for the 2012-2013 flu season.

Swine flu breaks out in Indiana

Swine flu has infected 113 people in Indiana, and that number is on the rise.

CDC preps for emerging swine flu strain

The U.S. Centers for Disease Control isn't taking any chances when it comes to swine flu. A new strain of the flu--H3N2--includes an element seen in the H1N1 swine flu pandemic of 2009, so the CDC is preparing a candidate vaccine and clinical trials for later this year.

Alnylam gets $3.2M milestone from GSK for vax tech

Alnylam Pharmaceuticals hit a development milestone for its VaxiRNA technology, receiving a $3.2 million payment from GlaxoSmithKline.

Medicago completes rapid-fire flu vaccine production

Medicago successfully completed an attempt to quickly deliver H1N1 VLP influenza vaccine candidates, slinging at least 10 million doses in one month.

Sanofi, Pitt team to develop universal seasonal flu vaccine

Sanofi Pasteur will join University of Pittsburgh scientists to develop a vaccine for all strains of seasonal influenza that will take as little as four months to produce.

Swine flu shots a success for Scotland

The Scottish authorities put a vaccination program in place for pandemic H1N1 2009 (swine flu) in October 2009, and a team of Scottish researchers have assessed its effectiveness in a paper published in The Lancet Infectious Diseases.